Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Clinical trial NCT06189638 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06189638
- Sponsor
- Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2027-04-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.